載入...
Optimising infliximab induction dosing for patients with ulcerative colitis
AIMS: The therapeutic failure of infliximab therapy in patients with ulcerative colitis remains a challenge even 2 decades after its approval. Therapeutic drug monitoring (TDM) has shown value during maintenance therapy, but induction therapy has still not been explored. Patients may be primary nonr...
Na minha lista:
| 發表在: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422726/ https://ncbi.nlm.nih.gov/pubmed/30634202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13859 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|